Company news

Patrys Limited news in 2021

Patrys Limited's news releases, calls and decks from 2021, newest first.

View company

Ceasing to be a substantial holder from MQG

December 8, 2021

Change of Director's Interest Notices x2

December 6, 2021

Rights Issue Results and Shortfall Notification

December 2, 2021

Notification regarding unquoted securities - PAB

November 22, 2021

Rights Issue Offer Document

November 8, 2021

$7.8M Capital Raising

October 31, 2021

Appendix 4C - Quarterly - 30 September 2021

October 19, 2021

Patrys proof of concept ADC significantly increases survival

October 17, 2021

PAT-DX3 proof of concept as potential ADC targeting antibody

September 14, 2021

Appendix 4E and 2021 Annual Report

August 25, 2021

Market Update - PAT-DX1 Clinical Trial Preparation

August 2, 2021

Appendix 4C - Quarterly - 30 June 2021

July 29, 2021

PAT-DX1 Improves Survival in Model of Pancreatic Cancer

July 25, 2021

Full size deoxymab PAT-DX3 crosses the blood brain barrier

July 11, 2021

Response to ASX Query

June 23, 2021

Patrys Limited Announces Publication of PAT-DX1 Preclinical Data in JCI - Insight

June 16, 2021

Paper highlights PAT-DX1 as potential brain cancer treatment

June 15, 2021

Patrys receives R&D Tax Incentive refund

June 9, 2021

Appendix 4C - Quarterly - 31 March 2021

April 27, 2021

New United States patent granted for Patrys deoxymab assets

March 30, 2021

Appendix 4D - Half Year Accounts - 31 December 2020

February 19, 2021

Patrys Successfully Establishes PAT-DX1 Stable Cell Line

February 9, 2021

Appendix 4C - Quarterly - 31 December 2020

January 27, 2021

Decks in 2021